5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.29▼ | 2.30▼ | 2.31▼ | 2.48▼ | 2.05▲ |
MA10 | 2.29▼ | 2.34▼ | 2.37▼ | 2.30▼ | 1.78▲ |
MA20 | 2.35▼ | 2.39▼ | 2.42▼ | 2.12▲ | 1.79▲ |
MA50 | 2.43▼ | 2.47▼ | 2.32▼ | 1.76▲ | 3.54▼ |
MA100 | 2.56▼ | 2.32▼ | 2.18▲ | 1.79▲ | 11.51▼ |
MA200 | 2.37▼ | 2.02▲ | 1.93▲ | 2.81▼ | 29.82▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.013▼ | -0.029▼ | 0.010▲ | 0.270▲ |
RSI | 39.918▼ | 38.568▼ | 41.279▼ | 56.470▲ | 48.354▼ |
STOCH | 38.739 | 20.271 | 14.777▼ | 64.286 | 75.029 |
WILL %R | -73.077 | -85.106▼ | -87.273▼ | -55.769 | -37.179 |
CCI | -59.574 | -101.227▼ | -111.832▼ | 5.519 | 199.787▲ |
Tuesday, February 11, 2025 03:14 AM
Short interest in NLS Pharmaceutics Ltd (NASDAQ:NLSP) decreased during the last reporting period, falling from 91.33K to 39.60K. This put 1.09% of the company's publicly available shares short.
|
Wednesday, December 04, 2024 10:15 AM
ZURICH, Dec. 4, 2024 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) (Nasdaq: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company ...
|
Tuesday, November 05, 2024 04:08 AM
NLS Pharmaceutics Ltd. (NASDAQ:NLSP) shares are moving higher on Monday after the company announced it entered into a definitive merger agreement with Kadimastem. What To Know: The combined ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.34 | 2.34 | 2.22 | 2.28 | 148,875 |
12/06/25 | 2.47 | 2.4872 | 2.30 | 2.39 | 103,274 |
11/06/25 | 2.55 | 2.5899 | 2.3601 | 2.43 | 277,421 |
10/06/25 | 2.61 | 2.61 | 2.35 | 2.53 | 548,195 |
09/06/25 | 2.62 | 2.86 | 2.49 | 2.75 | 1,690,287 |
06/06/25 | 2.20 | 2.30 | 2.10 | 2.30 | 533,446 |
05/06/25 | 1.90 | 2.2105 | 1.90 | 2.08 | 328,620 |
04/06/25 | 2.09 | 2.10 | 1.90 | 1.90 | 102,557 |
03/06/25 | 2.20 | 2.26 | 2.08 | 2.11 | 117,547 |
02/06/25 | 2.25 | 2.2878 | 2.08 | 2.21 | 141,042 |
|
|
||||
|
|
||||
|
|